The trajectory of Viagra presents a complex picture for shareholders. While the initial launch generated massive gains, the lapse of its patent opened the floodgates to off-brand versions, dramatically diminishing https://doctorbookmark.com/story21700272/sildenafil-and-the-pharmaceutical-industry-a-precarious-investment